BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Mankind Pharma Ltd

Pharmaceuticals

Offer Period :

25th to 27th Apr 2023

Established in 1991, Mankind Pharma is a leading Indian pharmaceutical company with a robust portfolio spanning anti-infectives, cardiovascular, and other therapeutic areas. Boasting 36 brands, including Manforce and Prega News, Read more... it ranks 4th in domestic sales and has an extensive distribution network and numerous accolades.Read less

Mankind Pharma Ltd IPO Details

IPO Date 25th to 27th Apr 2023 Minimum Investment ₹14040 / 1 Lots
Listing Date 2023-05-09 Maximum Investment ₹196560 / 14 Lots
Face Value ₹1 per share Total Issue Size ₹4326.36 Crores
Price ₹1080 to ₹1080 per share Fresh Issue ₹0 Crores
Lot Size 1 Lots (13 Shares) Offer For Sale ₹ 4326.36
Listing At BSE, NSE Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date 25th to 27th Apr 2023
Listing Date 2023-05-09
Face Value ₹1 per share
Price ₹1080 to ₹1080 per share
Lot Size 1 Lots (13 Shares)
Listing At BSE, NSE
Employee Discount ₹0 per share
Minimum Investment ₹14040 / 1 Lots
Maximum Investment ₹196560 / 14 Lots
Total Issue Size ₹4326.36 Crores
Fresh Issue ₹0 Crores
Offer For Sale
Retail Discount ₹ 0

Timeline

Important dates for allocation and IPO listing.

25th Apr

IPO Starts

27th Apr

IPO Ends

3rd May

Allotment Date

4th May

Initiation of Refund

8th May

Credit of Shares to Demat Account

9th May

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 67.29 0
Public Group 32.71 0

Mankind Pharma Ltd IPO Reservation

QIB Shares Offered 20029422(50%)
NII (HNI) Shares Offered 6008827(15%)
Retail Shares Offered 14020595(35%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 40058844
Total Shares With Anchor Investor 40058844

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Mankind Pharma Ltd IPO Registrar

KFin Techologies Ltd
Phone Number +91 40 6716 2222
Email Id mankind.ipo@kfintech.com
Our Website www.kfintech.com

Mankind Pharma Ltd IPO Lead Manager

1. Kotak Mahindra Capital Company Ltd

2. Axis Capital Ltd

3. Jefferies India Pvt Ltd

4. J.P.Morgan India Pvt Ltd

5. IIFL Securities Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Mankind Pharma Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Mankind Pharma Ltd

1. scaled domestic focused business with potential for further growth;

2. growing faster than the rate of the IPM with a focus on volume-led growth;

3. diversified portfolio with market leading rankings across key therapeutic areas;

4. established and growing consumer healthcare franchise with brand recall;

5. leveraged its corporate brand to build and scale brands;

6. ?wide market and distribution coverage with focus on affordability and accessibility;

7. significant and diversified manufacturing and R&D capabilities;

8. experienced and professional management team backed by private equity investors.

Risks Involved

1. The company is subject to extensive government regulations which are also subject to change. If the company fail to comply with the applicable regulations prescribed by the governments and the relevant regulatory agencies, its business, financial condition, cash flows and results of operations will be adversely affected.

2. The company is required to obtain, maintain or renew its statutory and regulatory approvals, licenses, and registrations to operate its business.

3. Any disruption, slowdown or shutdown in its manufacturing or R&D operations could adversely affect its business, financial condition, cash flows and results of operations.

4. The company inability to accurately forecast demand for its products and manage the company inventory may have an adverse effect on its business, financial condition, cash flows and results of operations.

5. Any failure to maintain and enhance, or any damage to, its brands, product image or reputation could adversely affect the market recognition of, and trust in, the company products.

6. Any delay, interruption or reduction in the supply of its raw materials or finished formulations from its third-party suppliers and manufacturers, or an increase in the costs of such raw materials and finished formulations, may adversely impact the pricing and supply of its products and have an adverse effect on the company business, financial condition, cash flows and results of operations.

7. If the company do not successfully develop or commercialize new products in a timely manner, or if the products that the company commercialize do not perform as expected, its business, results of operations and financial condition may be adversely affected.

8. The availability of counterfeit drugs, such as drugs passed off by others as its products, could adversely affect the company goodwill and results of operations.

9. Its inability to successfully implement the company business plan, expansion and growth strategies could have an adverse effect on its business, financial condition, cash flows and results of operations.

10. Any problems in its quality control or manufacturing processes may damage the company reputation, subject us to regulatory action and expose it to litigation or other liabilities.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023 2022
Total Assets 11963.25 9715.45 9147.74
Total Liabilities 11963.25 9715.45 9147.74
Total Expenses 8231.49 7219.19 6017.43
Total Revenue 
10615.63 8878 7977.58
Profit After Tax 1912.9 1281.86 1433.48
EBITDA 2831.14 2041.63 2199.83
Adjusted EBITDA 0 0 0

Mankind Pharma Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2023-05-09 543904 MANKIND
INE634S01028
₹1080 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹1080 ₹1080
Open ₹1300 ₹1300
Low ₹1300 ₹1300
High ₹1430 ₹1430
Low ₹1300 ₹1300

Frequently Asked Questions

What is Mankind Pharma Ltd IPO?

Answer Field

Mankind Pharma Ltd IPO is a Mainboard IPO of 4,00,58,844 equity shares of a face value of ₹1 aggregating up to ₹4326.36 Crores. The issue is priced at ₹1080 to ₹1080 per share. The minimum order quantity is 13 Shares. The IPO opens on April 25, 2023, and closes on April 27, 2023. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Mankind Pharma Ltd IPO will open?

Answer Field

The Mankind Pharma Ltd IPO opens on April 25, 2023 and closes on April 27, 2023.

What is the lot size of Mankind Pharma Ltd?

Answer Field

Mankind Pharma Ltd lot size is 13 shares, and the minimum amount required is ₹14,040.

How to apply for Mankind Pharma Ltd IPO?

Answer Field

You can apply in Mankind Pharma Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Mankind Pharma Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Mankind Pharma Ltd IPO will be done on May 03, 2023, and the allotted shares will be credited to your demat account by May 08, 2023.

When is Mankind Pharma Ltd IPO listing date?

Answer Field

The Mankind Pharma Ltd listing date is May 09, 2023.

Who is the registrar of Mankind Pharma Ltd IPO?

Answer Field

The registrar of Mankind Pharma Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Kotak Mahindra Capital Company Ltd,Axis Capital Ltd,Jefferies India Pvt Ltd,J.P.Morgan India Pvt Ltd,IIFL Securities Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Mankind Pharma Ltd IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Mankind Pharma Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 13 shares and ₹14,040 amount.

How can I approve the UPI mandate request for Mankind Pharma Ltd IPO?

Answer Field

To apply for Mankind Pharma Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Mankind Pharma Ltd?

Answer Field

The price of each Mankind Pharma Ltd share will be ranging in between ₹1080 to ₹1080 per share.

What is the cut-off time for the UPI mandate for Mankind Pharma Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, April 27, 2023.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • JUNGLE CAMPS INDIA LIMITEDSME IPO

  • Bidding Dates

    10th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹68.0 - 72.0

  • IPO Size

    ₹29,42,00,000

  • Apply Now
  • TOSS THE COIN LIMITEDSME IPO

  • Bidding Dates

    10th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹172.0 - 182.0

  • IPO Size

    ₹9,17,00,000

  • Apply Now
  • VISHAL MEGA MART LIMITEDMainboard IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹74.0 - 78.0

  • IPO Size

    ₹80,00,00,00,000

  • Apply Now
  • ONE MOBIKWIK SYSTEMS LIMITEDMainboard IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹265.0 - 279.0

  • IPO Size

    ₹5,72,00,00,000

  • Apply Now
  • PURPLE UNITED SALES LIMITEDSME IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹121.0 - 126.0

  • IPO Size

    ₹32,81,00,000

  • Apply Now
  • SAI LIFE SCIENCES LIMITEDMainboard IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹522.0 - 549.0

  • IPO Size

    ₹30,42,62,00,000

  • Apply Now
  • YASH HIGHVOLTAGE LIMITEDSME IPO

  • Bidding Dates

    12th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹138.0 - 146.0

  • IPO Size

    ₹1,10,01,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SWIGGY LIMITEDMainboard IPO

  • Bidding Dates

    6th Nov 2024 - 11th Nov 2024

  • Price Range

    ₹371.0 - 390.0

  • IPO Size

    ₹1,13,27,43,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • ONYX BIOTEC LIMITEDSME IPO

  • Issue Price

    61.00

  • Listing Day Close

    56.75

  • Listing Day (Gain/Loss)

    -6.56

  • SWIGGY LIMITEDMainboard IPO

  • Issue Price

    390.00

  • Listing Day Close

    455.95

  • Listing Day (Gain/Loss)

    16.92

  • DANISH POWER LIMITEDSME IPO

  • Issue Price

    380.00

  • Listing Day Close

    598.50

  • Listing Day (Gain/Loss)

    57.63

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text